{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:02:05Z","timestamp":1789664525481,"version":"4.0.1"},"reference-count":68,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:00:00Z","timestamp":1543708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014729","name":"Philip Morris International.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014729","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Background.<\/ns3:bold>\n                    Determining the public health impact of tobacco harm reduction strategies requires the assessment of consumer perception and behavior associated with tobacco and nicotine products (TNPs) with different exposure and risk profiles. In this context, rigorous methods to develop and validate psychometrically sound self-report instruments to measure consumers\u2019 responses to TNPs are needed.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Methods.<\/ns3:bold>\n                    Consistent with best practice guidelines, including the U.S. Food and Drug Administration\u2019s\n                    <ns3:italic>\u201cGuidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims,\u201d<\/ns3:italic>\n                    scientifically designed, fit-for-purpose, reliable, and valid instruments are now being applied to tobacco regulatory research.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Results.<\/ns3:bold>\n                    This brief report presents the ABOUT\u2122 Toolbox (\n                    <ns3:bold>A<\/ns3:bold>\n                    ssessment of\n                    <ns3:bold>B<\/ns3:bold>\n                    ehavioral\n                    <ns3:bold>OU<\/ns3:bold>\n                    tcomes related to\n                    <ns3:bold>T<\/ns3:bold>\n                    obacco and nicotine products) initiative. This communication: (1)\u00a0describes the methodological steps followed for the development and validation of the measurement instruments included in the ABOUT\u2122 Toolbox, (2)\u00a0presents a summary of the high-priority tobacco-related domains that are currently covered in the ABOUT\u2122 Toolbox (i.e.,\u00a0risk perception, dependence, product experience, health and functioning, and use history), and (3)\u00a0details how the measurement instruments are made accessible to the scientific community.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Conclusions.<\/ns3:bold>\n                    By making the ABOUT\u2122 Toolbox available to the tobacco research and public health community, we envision a rapidly expanding knowledge base, with the goals of (1) supporting consumer perception and behavior research to allow comparisons across a wide spectrum of TNPs, (2) enabling public health and regulatory communities to make better-informed decisions for future regulation of TNPs, and (3) enhancing surveillance activities associated with the impact of TNPs on population health.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.16810.1","type":"journal-article","created":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T06:00:06Z","timestamp":1543730406000},"page":"1878","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT\u2122 Toolbox initiative"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-5312","authenticated-orcid":false,"given":"Christelle","family":"Chrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-7989","authenticated-orcid":false,"given":"Catherine","family":"Acquadro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8866-4765","authenticated-orcid":false,"given":"Esther F.","family":"Afolalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Abetz-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Mainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Weitkunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2018,12,2]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"193-213","DOI":"10.1146\/annurev-publhealth-040617-013849","article-title":"Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.","volume":"39","author":"D Abrams","year":"2018","journal-title":"Annu Rev Public Health."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"76-93","DOI":"10.18001\/TRS.1.1.8","article-title":"Providing a Science Base for the Evaluation of Tobacco Products.","volume":"1","author":"M Berman","year":"2015","journal-title":"Tob Regul Sci."},{"key":"ref-3","article-title":"The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General","year":"2014"},{"key":"ref-4","article-title":"The Health Benefits of Smoking Cessation. A Report of the Surgeon General."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"324-332","DOI":"10.1136\/tc.2008.027318","article-title":"The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.","volume":"18","author":"M Zeller","year":"2009","journal-title":"Tob Control."},{"key":"ref-6","doi-asserted-by":"publisher","article-title":"Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction.","year":"2001","DOI":"10.17226\/10029"},{"key":"ref-7","article-title":"Monograph: Advancing Knowledge on Regulating Tobacco Products.","year":"2009"},{"key":"ref-8","article-title":"Guidance for industry - Modified Risk Tobacco Product Applications - Draft Guidance.","year":"2012"},{"key":"ref-9","doi-asserted-by":"publisher","article-title":"Scientific standards for studies on modified risk tobacco products.","year":"2012","DOI":"10.17226\/13294"},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"3225-3240","DOI":"10.1158\/1055-9965.EPI-09-0946","article-title":"Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods.","volume":"18","author":"V Rees","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"ref-11","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2017-054005","article-title":"A review of risk perception measurement in tobacco control research.","author":"A Kaufman","year":"2018","journal-title":"Tob Control."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"S170-174","DOI":"10.1093\/ntr\/ntu086","article-title":"The PROMIS smoking assessment toolkit--background and introduction to supplement.","volume":"16 Suppl 3","author":"M Edelen","year":"2014","journal-title":"Nicotine Tob Res."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"S175-189","DOI":"10.1093\/ntr\/ntt123","article-title":"Methodology for developing and evaluating the PROMIS smoking item banks.","volume":"16 Suppl 3","author":"M Hansen","year":"2014","journal-title":"Nicotine Tob Res."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"S250-260","DOI":"10.1093\/ntr\/ntu065","article-title":"The PROMIS Smoking Initiative: initial validity evidence for six new smoking item banks.","volume":"16 Suppl 3","author":"M Edelen","year":"2014","journal-title":"Nicotine Tob Res."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"S261-262","DOI":"10.1093\/ntr\/ntu094","article-title":"Delivering on its promises: the PROMIS Smoking Initiative item banks.","volume":"16 Suppl 3","author":"R Niaura","year":"2014","journal-title":"Nicotine Tob Res."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"80-84","DOI":"10.1016\/j.addbeh.2016.02.035","article-title":"Additional validity evidence for the PROMIS Smoking Assessment Toolkit.","volume":"58","author":"M Edelen","year":"2016","journal-title":"Addict Behav."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"361-365","DOI":"10.1093\/ntr\/ntv083","article-title":"The Psychometric Performance of the PROMIS Smoking Assessment Toolkit: Comparisons of Real-Data Computer Adaptive Tests, Short Forms, and Mode of Administration.","volume":"18","author":"B Stucky","year":"2016","journal-title":"Nicotine Tob Res."},{"key":"ref-18","article-title":"Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims.","year":"2009"},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2288-10-22","article-title":"The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content.","volume":"10","author":"L Mokkink","year":"2010","journal-title":"BMC Med Res Methodol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"193-205","DOI":"10.1023\/A:1015291021312","article-title":"Assessing health status and quality-of-life instruments: attributes and review criteria.","volume":"11","author":"N Aaronson","year":"2002","journal-title":"Qual Life Res."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"207-211","DOI":"10.1177\/1558689807302814","article-title":"Editorial: Exploring the nature of research questions in mixed methods research.","volume":"1","author":"A Tashakkori","year":"2007","journal-title":"J Mix Methods Res."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-017-0718-x","article-title":"Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures.","volume":"12","author":"T Morel","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"978-988","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.","volume":"14","author":"D Patrick","year":"2011","journal-title":"Value Health."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"967-977","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.","volume":"14","author":"D Patrick","year":"2011","journal-title":"Value Health."},{"key":"ref-25","first-page":"32-42","article-title":"Perceived risks associated with the use of tobacco and nicotine-containing products: Findings from qualitative research.","volume":"50","author":"T Salzberger","year":"2017","journal-title":"Tobacco Science and Technology."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"A505","DOI":"10.1016\/j.jval.2015.09.1439","article-title":"Factors Influencing Consumers' Perceived Risk Of Tobacco Products.","volume":"18","author":"M Atkinson","year":"2015","journal-title":"Value Health."},{"key":"ref-27","article-title":"Development of a tobacco and nicotine products dependence instrument.","author":"C Chrea"},{"key":"ref-28","doi-asserted-by":"crossref","DOI":"10.4135\/9781412985598","article-title":"Rasch models for measurement.","author":"D Andrich","year":"1988"},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"297-334","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests.","volume":"16","author":"L Cronbach","year":"1951","journal-title":"Psychometrika."},{"key":"ref-30","article-title":"Scale development: theory and applications.","author":"R DeVellis","year":"2003"},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"571-585","DOI":"10.1586\/erp.11.59","article-title":"Rating scales and Rasch measurement.","volume":"11","author":"D Andrich","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"33-80","DOI":"10.2307\/270846","article-title":"An elaboration of Guttman scaling with Rasch models for measurement.","volume":"15","author":"D Andrich","year":"1985","journal-title":"Sociol Methodol."},{"key":"ref-33","first-page":"59-70","article-title":"Diagnostic opportunities with the Rasch model for ordered response categories.","author":"D Andrich","year":"1997","journal-title":"Applications of latent trait and latent class models in the social sciences."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"561-573","DOI":"10.1007\/BF02293814","article-title":"A rating formulation for ordered response categories.","volume":"43","author":"D Andrich","year":"1978","journal-title":"Psychometrika."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"387-416","DOI":"10.3102\/1076998611411913","article-title":"Real and artificial differential item functioning.","volume":"37","author":"D Andrich","year":"2012","journal-title":"J Educ Behav Stat."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"A765-A766","DOI":"10.1016\/j.jval.2017.08.2180","article-title":"Using Rasch measurement to quantify the perceived risks associated with the use of tobacco and nicotine-containing products.","volume":"20","author":"C Chrea","year":"2017","journal-title":"Value Health."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12955-018-0997-5","article-title":"Development and validation of a new instrument to measure perceived risks associated with the use of tobacco and nicotine-containing products.","volume":"16","author":"S Cano","year":"2018","journal-title":"Health Qual Life Outcomes."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"237-247","DOI":"10.1023\/A:1026410721664","article-title":"'Equivalence' and the translation and adaptation of health-related quality of life questionnaires.","volume":"6","author":"M Herdman","year":"1997","journal-title":"Qual Life Res."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"323-335","DOI":"10.1023\/A:1024985930536","article-title":"A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach.","volume":"7","author":"M Herdman","year":"1998","journal-title":"Qual Life Res."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"273-277","DOI":"10.1007\/s11136-014-0765-x","article-title":"Pooling of cross-cultural PRO data in multinational clinical trials: how much can poor measurement affect statistical power?","volume":"24","author":"A Regnault","year":"2015","journal-title":"Qual Life Res."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"94-104","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.","volume":"8","author":"D Wild","year":"2005","journal-title":"Value Health."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"430-440","DOI":"10.1111\/j.1524-4733.2008.00471.x","article-title":"Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report.","volume":"12","author":"D Wild","year":"2009","journal-title":"Value Health."},{"key":"ref-43","article-title":"Linguistic validation of the Perceived Risk Instrument (PRI) into French, German, Italian, Japanese, Polish and Russian.","author":"C Acquadro"},{"key":"ref-44","first-page":"15-117","article-title":"Chapter 1: Linguistic Validation Procedures.","author":"I Mear","year":"2012","journal-title":"Linguistic Validation Manual for Health Outcome Assessments."},{"key":"ref-45","article-title":"Psychometric evaluation of the mCEQ applied to cigarettes and heat-not-burn products in the US and Japan.","author":"T Salzberger"},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"115-124","DOI":"10.1007\/s11136-014-0722-8","article-title":"Using quantitative methods within the Universalist model framework to explore the cross-cultural equivalence of patient-reported outcome instruments.","volume":"24","author":"A Regnault","year":"2015","journal-title":"Qual Life Res."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41687-018-0035-8","article-title":"Emerging good practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) measures.","volume":"2","author":"C Acquadro","year":"2017","journal-title":"J Patient Rep Outcomes."},{"key":"ref-48","doi-asserted-by":"crossref","first-page":"A399","DOI":"10.1016\/S1098-3015(10)74968-8","article-title":"The advantages of a centralized dissemination stratefy for health outcomes instruments and their translations: A case exemple with the Zarit Burden Interview (ZBI).","volume":"12","author":"C Anfray","year":"2009","journal-title":"Value Health."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7525-10-16","article-title":"Questions of copyright.","volume":"10","author":"C Anfray","year":"2012","journal-title":"Health Qual Life Outcomes."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-3-12","article-title":"Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions.","volume":"3","author":"M Emery","year":"2005","journal-title":"Health Qual Life Outcomes."},{"key":"ref-51","first-page":"76-101","article-title":"Monitoring tobacco use.","year":"1998","journal-title":"Guidelines for Controlling and Monitoring the Tobacco Epidemic."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"638-648","DOI":"10.2478\/cttr-2013-0940","article-title":"Assessment of cigarette smoking in epidemiologic studies.","volume":"25","author":"R Weitkunat","year":"2013","journal-title":"Beitr\u00e4ge zur Tabakforschung International\/Contributions to Tobacco Research."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"224-239","DOI":"10.1515\/cttr-2017-0023","article-title":"Accuracy of the smoking questionnaire.","volume":"27","author":"Z Sponsiello-Wang","year":"2017","journal-title":"Beitr\u00e4ge zur Tabakforschung International\/Contributions to Tobacco Research."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"95-99","DOI":"10.1016\/j.addbeh.2017.07.025","article-title":"Evaluating the utility of subjective effects measures for predicting product sampling, enrollment, and retention in a clinical trial of a smokeless tobacco product.","volume":"76","author":"R O'Connor","year":"2018","journal-title":"Addict Behav."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"3209-3224","DOI":"10.1158\/1055-9965.EPI-09-0971","article-title":"Measures for assessing subjective effects of potential reduced-exposure products.","volume":"18","author":"K Hanson","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"912-923","DOI":"10.1016\/j.addbeh.2006.06.028","article-title":"Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.","volume":"32","author":"J Cappelleri","year":"2007","journal-title":"Addict Behav."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1259-1264","DOI":"10.1093\/ntr\/nts265","article-title":"Subjective responses to oral tobacco products: scale validation.","volume":"15","author":"D Hatsukami","year":"2013","journal-title":"Nicotine Tob Res."},{"key":"ref-58","article-title":"Public Health Consequences of E-Cigarettes."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"1382-1390","DOI":"10.1093\/ntr\/nts007","article-title":"Dependence on tobacco and nicotine products: a case for product-specific assessment.","volume":"14","author":"K Fagerstrom","year":"2012","journal-title":"Nicotine Tob Res."},{"key":"ref-60","doi-asserted-by":"crossref","first-page":"185-193","DOI":"10.1016\/j.drugalcdep.2015.03.040","article-title":"Measurement of multiple nicotine dependence domains among cigarette, non-cigarette and poly-tobacco users: Insights from item response theory.","volume":"152","author":"D Strong","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref-61","doi-asserted-by":"crossref","first-page":"257-266","DOI":"10.1016\/j.drugalcdep.2017.05.010","article-title":"Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study.","volume":"178","author":"D Strong","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"ref-62","article-title":"International Classification of Functioning, Disability and Health: ICF","year":"2001"},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"336-342","DOI":"10.1111\/j.1547-5069.2005.00058.x","article-title":"Conceptual model of health-related quality of life.","volume":"37","author":"C Ferrans","year":"2005","journal-title":"J Nurs Scholarsh."},{"key":"ref-64","article-title":"Section 911 of the Federal Food, Drug, and Cosmetic Act - Modified Risk Tobacco Products"},{"key":"ref-65","article-title":"Notice Announcing Availability of Common Data Elements for Tobacco Regulatory Research via the PhenX Toolkit"},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"iii3-11","DOI":"10.1136\/tc.2005.015438","article-title":"The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project.","volume":"15 Suppl 3","author":"G Fong","year":"2006","journal-title":"Tob Control."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"371-378","DOI":"10.1136\/tobaccocontrol-2016-052934","article-title":"Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.","volume":"26","author":"A Hyland","year":"2017","journal-title":"Tob Control."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"351-377","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs.","volume":"15","author":"K McLeroy","year":"1988","journal-title":"Health Educ Q."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T11:35:43Z","timestamp":1616585743000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,2]]},"references-count":68,"URL":"https:\/\/doi.org\/10.12688\/f1000research.16810.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.18377.r43288","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.18377.r44881","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.18377.r44881","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.18377.r43288","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,2]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.18377.r43288, Christopher Proctor, R&D Centre, British American Tobacco (Investments) Ltd., Southampton, UK, 12 Feb 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1#referee-response-43288","order":0,"name":"referee-response-43288","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.18377.r44881, Michael Balls, Robert D. Combes, University of Nottingham, Nottingham, UK, 08 Mar 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1878\/v1#referee-response-44881","order":1,"name":"referee-response-44881","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The work presented in this communication was sponsored by Philip Morris International.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}